What is ConcertoCare?
ConcertoCare operates as a leading risk-bearing provider specializing in field-based complex care for persistently high-cost and rising-risk patient populations. The company's multidisciplinary care teams deliver essential services directly to patients, whether in their homes or hospitals. This patient-centric model has demonstrated a strong track record of improving overall health quality and outcomes, notably reducing hospital admissions by 47%, readmissions by 40%, and ER visits by 16% for some of America's most vulnerable individuals. ConcertoCare's approach benefits patients, payers, and provider networks by enhancing care efficiency and effectiveness.
How much funding has ConcertoCare raised?
ConcertoCare has raised a total of $188.1M across 6 funding rounds:
Private Equity
$15.4M
Debt
$7.2M
Debt
$15.2M
Private Equity
$15.2M
Private Equity
$30M
Series B
$105M
Private Equity (2012): $15.4M, investors not publicly disclosed
Debt (2013): $7.2M, investors not publicly disclosed
Debt (2013): $15.2M, investors not publicly disclosed
Private Equity (2015): $15.2M, investors not publicly disclosed
Private Equity (2016): $30M backed by Deerfield Management Company and Arboretum Ventures
Series B (2022): $105M with participation from Deerfield, Charles and Lynn Schusterman Family Foundation, SteelSky Ventures, Wells Fargo Capital Finance, The Obvious, Vast Ventures, and Pennington Partners
Key Investors in ConcertoCare
Deerfield Management Company
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy. The firm supports companies across the healthcare ecosystem with flexible funding models and drives innovation using AI, data, and market research.
Charles and Lynn Schusterman Family Foundation
Schusterman Family Investment Office is a venture capital company. It offers seed funding and investment services. The company was formed in 1987 and is based in Tulsa, Oklahoma.
SteelSky Ventures
SteelSky Ventures is a visionary venture fund focused on investing in companies that enhance access, care, and outcomes in women's health. With $73 million in assets under management, they support innovations across consumer health, digital health, and healthcare infrastructure.
What's next for ConcertoCare?
The recent major strategic investment, likely a Series B round given the context, positions ConcertoCare for accelerated growth and market penetration. This capital will likely be deployed to scale its innovative care model, expand its geographic reach, and further develop its technological infrastructure to support its complex care operations. The company's focus on improving outcomes for high-cost populations aligns with broader healthcare trends towards value-based care and integrated health solutions, suggesting a strong future outlook for continued investment and strategic partnerships.
See full ConcertoCare company page
